VCA Antech Inc. 12401 West Olympic Boulevard Los Angeles,
CA 90064-1022 United States - Map Phone: 310-571-6500 Fax: 310-571-6700 Website: http://www.vcaantech.com
VCA Antech, Inc. operates as an animal healthcare company in the United States and Canada. The companys Animal Hospital segment offers general medical and surgical services, as well as specialized treatments comprising advanced diagnostic services, internal medicine, oncology, ophthalmology, dermatology, and cardiology for companion animals; retail and pharmaceutical products; specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and services, such as grooming, bathing, and boarding services. Its Laboratory segment provides testing and consulting services in the areas of chemistry, pathology, endocrinology, serology, hematology, and microbiology, as well as conducts tests specific to particular diseases. This segment serves animal hospitals, animal practices, universities, and other government organizations. VCA Antech, Inc. also offers digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market; online and printed communications, professional education, and marketing solutions to the veterinary community; and an e-commerce platform for independent animal hospitals. In addition, the company provides technical support and product updates; professional services related to its equipment and software, including installations, on-site training, education services, and extended warranty programs; and mobile imaging services, as well as licenses software. As of December 31, 2011, it operated 541 animal hospitals and 53 veterinary diagnostic laboratories. The company also serves veterinary practices, pharmaceutical manufacturers, and the pet owning community. VCA Antech, Inc. was founded in 1986 and is headquartered in Los Angeles, California. Key Statistics
| |
| VCA Antech Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Medium Concern), Board (High Concern), Compensation (High Concern), Shareholder Rights (High Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Robert L. Antin ,
62 Co-Founder, Chairman, Chief Exec. Officer and Pres | 1.94M | 1.57M | Mr. Arthur J. Antin ,
65 Co-Founder, Chief Operating Officer and Sr. VP | 1.20M | 193.00K | Mr. Neil Tauber ,
61 Co-Founder and Sr. VP of Devel. | 762.00K | 0.00 | Mr. Tomas W. Fuller ,
54 Chief Financial Officer, Principal Accounting Officer, VP and Sec. | 711.00K | 0.00 | Mr. Josh Drake ,
44 Pres of Laboratory Division - Antech Diagnostics | 495.00K | 0.00 |
|
| | Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|